Invesco Nasdaq Biotechnology ETF
Ticker
IBBQ
ISIN
US46138G599
Price
USD 22.19
Change Today
-0.20 / -0.881 %
Price 1 year ago
19.85 / 11.789 %
Morningstar
-
52 Week Low
20.16
52 Week High
24.57
200 Day Moving Average 22.84
22.84
50-day Moving Average
23.32
Price evolution
Yearly returns
Peers comparison
Risk factors
1 year
Parameter | Value |
---|---|
Sharpe Ratio | 1.28 |
Sortino Ratio | 0.34 |
Maximum Drawdown | -2.9% |
Maximum Drawdown Date | 2023-12-20 |
Calmar Ratio | -40.12 |
1 year
Parameter | Value |
---|---|
Treynor Ratio | - |
Return | 2.48 |
Volatility | 6.121% |
Alpha | +9.42 |
Beta | -- |
R Squared | +59.85 |
History
Parameter | Value |
---|---|
Average Annual Return | -0.833% |
Average Annual Volatility | 21.632% |
Sharpe Ratio | -0.04 |
Sortino Ratio | -0.24 |
Maximum Drawdown | -38.0% |
Maximum Drawdown Date | 2022-06-13 |
Calmar Ratio | 0.04 |
Company information
Summary
The investment seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index ®. The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
Market
US
Category
Health
Expense Ratio
0.19%
Fund family
Invesco
Morningstar
-
Yield
-
Exchange
NGM
Sector | Weight |
---|---|
Healthcare | 99.89% |
Realestate | 0.00% |
Consumer cyclical | 0.00% |
Basic materials | 0.00% |
Consumer defensive | 0.00% |
Technology | 0.00% |
Communication services | 0.00% |
Financial services | 0.00% |
Utilities | 0.00% |
Industrials | 0.00% |
Energy | 0.00% |
Country | Ratio |
---|---|
United States | 87.13 |
United Kingdom | 5.46 |
China | 1.71 |
France | 1.51 |
Germany | 1.23 |
Denmark | 1.21 |
Canada | 0.75 |
Switzerland | 0.36 |
Ireland | 0.25 |
Netherlands | 0.17 |
Holdings
Symbol | Name | Allocation |
---|---|---|
AMGN | Amgen Inc | 7.59% |
MRNA | Moderna Inc | 7.38% |
GILD | Gilead Sciences Inc | 6.75% |
ILMN | Illumina Inc | 5.4% |
REGN | Regeneron Pharmaceuticals Inc | 4.12% |
BIIB | Biogen Inc | 4.1% |
VRTX | Vertex Pharmaceuticals Inc | 4.08% |
ALXN | Alexion Pharmaceuticals Inc | 3.2% |
SGEN | Seagen Inc Ordinary Shares | 2.26% |
AZN.L | AstraZeneca PLC ADR | 1.68% |
Alternative funds
Ticker | Name | Isin | Exchange | Expenses | Morningstar | Alpha | Beta |
---|---|---|---|---|---|---|---|
BTEC.L | iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) | IE00BYXG2H3 | LSE | 0.35% | 4 | -0.49 | |
BTEE.L | iShares Nasdaq US Biotechnology UCITS ETF | IE00BYXG2H3 | LSE | 0.35% | 4 | -0.48 | -- |
BTEK.L | iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) | IE00BYXG2H3 | LSE | 0.35% | 4 | -0.49 | |
CIBR | First Trust NASDAQ Cybersecurity ETF | US33734X846 | NGM | 0.60% | 4 | -9.46 | |
CNDX.L | iShares NASDAQ 100 UCITS ETF USD (Acc) | IE00B53SZB1 | LSE | 0.36% | 5 | -0.78 | |
EQQQ.L | Invesco EQQQ NASDAQ-100 UCITS ETF | IE003207701 | LSE | 0.30% | 5 | -0.72 | |
ONEQ | Fidelity Nasdaq Composite Index ETF | US315912808 | NGM | 0.21% | 4 | -7.93 | |
QQEW | First Trust NASDAQ-100 Equal Weighted Index Fund | US337344105 | NGM | 0.57% | 4 | -0.08 | |
QQXT | First Trust NASDAQ-100 Ex-Technology Sector Index Fund | US33733E401 | NGM | 0.60% | 4 | +9.50 | |
SBIO.L | Invesco NASDAQ Biotech UCITS ETF | IE00BQ70R69 | LSE | 0.40% | 4 | -0.39 | |
UST.PA | Lyxor Nasdaq-100 Ucits ETF | FR0007063177 | PAR | 0.30% | 5 | -0.600 |
Sustainability scores
Events
Indicators
Glossary
- Momentum
- A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
- Inertia
- In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
- Relative Strength Index (RSI)
- A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
- Fibonacci's Weighted Moving Average
- A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
- Williams %R
- A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
- Relative Volatility Index (RVI)
- A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
- Commodity Channel Index (CCI)
- A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.